Safety profile of ripretinib, including impact of alopecia, and Palmar-Plantar Erythrodysesthesia Syndrome (PPES) on patient-reported outcomes (PROs), in ≥ fourth-line advanced gastrointestinal stromal tumors (GIST): Analyses from INVICTUS Meeting Abstract


Authors: George, S.; Heinrich, M. C.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schoffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G. Z.; Chi, P.; Reichardt, P.; Lacouture, M. E.; Cha, E.; Meade, J. N.; Ruiz-Soto, R.; Blay, J. Y.; von Mehren, M.
Abstract Title: Safety profile of ripretinib, including impact of alopecia, and Palmar-Plantar Erythrodysesthesia Syndrome (PPES) on patient-reported outcomes (PROs), in ≥ fourth-line advanced gastrointestinal stromal tumors (GIST): Analyses from INVICTUS
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 15 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-05-20
Start Page: 559s
Language: English
ACCESSION: WOS:000560368300400
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.15_suppl.11539
Notes: Meeting Abstract: 11539 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mario E Lacouture
    457 Lacouture
  2. Ping Chi
    172 Chi